CatSci Ltd will be attending the RNA Leaders Europe Congress conference on 13th – 14th March 2024. Hosted at the Congress Centre Basel, this event will bring together key stakeholders to examine the current and future challenges and opportunities of RNA therapeutics. Facilitating two days of learning and networking, the conference aims to forge collaborations that will bring new discoveries to market.
Our Oligonucleotide Group Lead, Dr Aled Williams, and our Business Development Manager, Ali Albeckai, will be attending this two-day conference. They are excited to network with like-minded individuals and explore how CatSci’s in-depth expertise enables the synthesis of all classes of therapeutics oligos, including siRNA, ASO, Gapmers and sgRNA, as well as GalNAc ligands and other conjugates at up to a 30g scale.
Our in-depth expertise in oligonucleotide R&D and manufacturing, along with our GMP-analytical services, method development, CMC expertise, including process optimisation studies for each unit operation in the oligonucleotide manufacturing process, as well as DoE optimisation and Quality by Design
We also possess CMC expertise, including process optimisation studies for each unit operation in the oligonucleotide manufacturing process, as well as DoE optimisation and Quality by Design.
If you would like to book a meeting with Aled and Ali, get in touch here.